PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts, USA.\', \'Business of Merck KGaA, Darmstadt, Germany.\', \'Merck Healthcare KGaA, Darmstadt, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/cpt.1879
?:hasPublicationType
?:journal
  • Clinical pharmacology and therapeutics
is ?:pmid of
?:pmid
?:pmid
  • 32356569
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.699
?:rankingScore_hIndex
  • 169
?:title
  • Challenges in Drug Development Posed by the COVID-19 Pandemic: An Opportunity for Clinical Pharmacology.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all